Announcing Four e-Books from BioMed e-Series: Series B,C,D,E: Genomics, Cancer, Metabolomics, Physiology & Therapeutics | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Researchers Create A Simulated Mouse Brain in a Virtual Mouse Body

Genomics Diagnostics Companies attractive to Institutional Investors »

Announcing Four e-Books from BioMed e-Series: Series B,C,D,E: Genomics, Cancer, Metabolomics, Physiology & Therapeutics

March 10, 2015 by 2012pharmaceutical

Announcing Four e-Books from BioMed e-Series: Series B,C,D,E: Genomics, Cancer, Metabolomics, Physiology & Therapeutics

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/biomed-e-books/

About Larry H Bernstein, MD, FCAP

http://pharmaceuticalintelligence.com/2014/10/16/editorial-publication-of-articles-in-e-books-by-leaders-in-pharmaceutical-business-intelligence-contributions-of-larry-h-bernstein-md-fcap/

About Stephen J Williams, PhD

http://pharmaceuticalintelligence.com/contributors-biographies/senior-editors/stephen-j-williams-phd-pharmacology-bsc-toxicology-expert-author-writer/

About Aviva Lev-Ari, PhD, RN, BioMed e-Series, Editor-in-Chief

http://pharmaceuticalintelligence.com/founder/editorial-publication-of-articles-in-e-books-by-leaders-in-pharmaceutical-business-intelligence/

About Tilda Barliya, PhD

http://pharmaceuticalintelligence.com/contributors-biographies/senior-editors/tilda-barliya-phd-expert-author-writer-research-category-owner-nanotechnology-for-drug-delivery/

About Ritu Saxena, PhD

http://pharmaceuticalintelligence.com/contributors-biographies/experts-authors-writers-eaws/ritu-saxena/

Posted in Academic Publishing, Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Computational Biology/Systems and Bioinformatics, Curation, Gene Regulation, Gene Regulation and Evolution, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, Genomic Expression, Genomic Testing: Methodology for Diagnosis, Genomics Pharmacy, Intellectual Property, Metabolomics, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Drug Discovery, Pharmacogenomics, Population Health Management, Population Health Management, Genetics & Pharmaceutical, Population Health Management, Nutrition and Phytochemistry, Proteomics | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,459 other subscribers
Recent Posts
- Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
- The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
- Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
- Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
- Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
- Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
- Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
- Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: